DMII

Conviction 61FinancialsScan · Mon, Oct 12, 2026

Drugs Made In America Acquisition II Corp. (DMII) closed at $10.19 (+0.00%) on Oct 12, 2026. Price is above its 50-day. RSI(14) 63, at a 52-week high, +2.9% year to date. Sector: Financials · Blank Checks.

DMII$10.19+0.00%

ResistanceSupportVol 14

Vol MA14 735.77K

Jun 30Jul 17Aug 18Sep 3Sep 23Oct 12

Drugs Made In America Acquisition II Corp.Blank Checks

Price10.19

Change+0.00%

Gap+0.00%

Rel volume86.17×

Avg volume556.11K

Avg $ vol5.67M

SMA 2010.18

SMA 5010.15

SMA 200—

Price vs 50+0.40%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 10.15

RSI (14)63

MACD hist0.00

MACD crossbull · 6d

Stoch %K / %D80 / 41

ADX (14)66

+DI / −DI54 / 10

RSI divergence—

MACD divergence—

ATR %0.15%

ADR %0.16%

52w high10.19

52w low9.87

From 52w high+0.00%

Above 52w low+3.24%

New 52w highYes

SqueezeOff

Bollinger width0.55%

%B0.77

Donchian pos22.22%

Donchian high10.33

Donchian low10.15

AVWAP (52w high)10.19

vs AVWAP high+0.00%

AVWAP (52w low)10.07

vs AVWAP low+1.20%

OBV trendFlat

Chaikin MF (20)-0.01

Today vs 20d86.17×

Avg vol (14d)735.77K

Avg vol (20d)556.11K

Avg $ vol (20d)5.67M

Market cap649.1M

RS Rating—

RS 3m (vs SPY)-3.81%

RS 6m (vs SPY)-15.61%

RS line new highNo

Trend template—

Technical rank64.7

1 week+0.00%

1 month+0.20%

3 months+1.19%

6 months+2.31%

1 year—

YTD+2.93%

P/E155.03

P/B-36.21

P/S—

P/FCF—

EPS—

Div yield—

ROE-23.36%

ROA0.81%

Debt/Eq-0.03

Current0.34

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional71.37%

Ent. value649.38M

Revenue—

Net income4.4M

Gross profit—

Free cash flow—

IndustryBlank Checks

ExchangeNasdaq

Shares out63.7M

Employees2

ListedWed, Dec 3, 2025

Free float60.34M

Float %94.7%

Short interest119.32K

Days to cover1.9d

Short volume0.0%

Squeeze score25 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction61 / 100

Pattern quality—

Tech rank64.7 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance10.25

Support10.12

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jul 20 – Jul 23
4 scans
→
Breaking out now
Jul 24
1 scan
→
Broke out
Jul 27
1 scan
→
Retesting breakout
Jul 28 – Jul 29
2 scans
→
Setting up
Jul 30 – Sep 14
5 scans

Congress activity

Disclosed STOCK Act trades in DMII

All disclosures →

No recent disclosed trades by Congress in DMII. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DMII

No recent insider (Form 4) filings in DMII. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in DMII · 1 recent

EDGAR →

10-K/Q10-QQuarterly reportFri, Aug 14, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.